Central Bank & Trust CO Organon & Co. Transaction History

Central Bank & Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	BUY	$21.42 - $32.08 $771 - $1,154	36 New	36 $0
Q1 2022 Apr 18, 2022	SELL	$30.45 - $39.36 $4,963 - $6,415	-163 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$28.67 - $37.13 $3,870 - $5,012	135 Added 482.14%	163 $5,000
Q3 2021 Oct 19, 2021	SELL	$28.63 - $35.64 $28,715 - $35,746	-1,003 Reduced 97.28%	28 $1,000
Q2 2021 Jul 16, 2021	BUY	$28.45 - $38.0 $29,331 - $39,178	1,031 New	1,031 $31,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Bank & Trust CO with notifications on news.